Find a Tender
complete
Official procurement procedure
Covid-19: DHSC: NHSX - Remote Symptoms Tracking System, App and supply of SpO2 Devices
Medical software package
Patient-monitoring system
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Department of Health and Social Care: "Covid-19: DHSC: NHSX - Remote Symptoms Tracking System, App and supply of SpO2 Devices". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | Department of Health and Social Care | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: Department of Health and Social Care
Market Analytics
Derived from OCDS awards & bid statistics
Published history for Department of Health and Social Care. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
11.8Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 451 active published awards; 397 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityDepartment of Health and Social Care | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published6 Mar 2021, 10:17 GMT | Last source update6 Mar 2021, 10:17 GMT | Recurring procurementNot published |
ClassificationMedical software package, Patient-monitoring system | ||
Delivery area | ||
OCIDocds-h6vhtk-029925 | ||
What is being bought
This procurement was awarded in April 2020 for access to the "Medopad software as a service and Application" for a pilot in two London NHS Trusts.The supplier was selected as they hold the IPR or provision of their remote system, mobile application. This was provided pro bono for the period 20/04/20 to 31/12/20 inclusive. However, DHSC had to purchase 20,000 Pulse Oximeters at pace to allocate to the Pilot's patients, and these were in short supply and high demand in April 2020, as a number of countries were rolling out a similar pilot scheme. DHSC agreed one-off supply contract for these Pulse Oximeters via Huma's supply chain to ensure stock was available immediately, and configured to meet the Pilot's specification.
What changed
From the official release history
- Status changed to complete
6 Mar 2021, 10:17 GMT - Official notice release published
6 Mar 2021, 10:17 GMT - Buyer information updated
6 Mar 2021, 10:17 GMT
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcancelledPublished valueNot publishedA programme to deploy remote monitoring of COVID patientsNHSX was reviewing the deployment of remote monitoring to ensure that patients have access to medical care during the Covid19 pandemic. Medopad (owned by Huma Therapeutics Ltd) is a remote monitoring product that had completed the Digital Health London accelerator, and had approached NHSX (following the national call for innovator assistance) following their similar work with other EU governments, as part of their Covid19 response. The two use cases is for this programme of work were to perform daily monitoring on the Covid-19 patients that had been recently discharged from hospital and provide an electronic monitoring of potential Covid-19 patients who were routed through primary care hot hubs. Both use cases allowed the early identification of deterioration of patients and ensure that health professionals could intervene before their patients found it difficult to breath and had long lasting damage to their lungs. This procurement was for access to the "Medopad software as a service and Application" for a pilot in two London NHS Trusts.The supplier was selected as they hold the IPR or provision of their remote system, mobile application. This was provided pro bono for the period 20/04/20 to 31/12/20 inclusive. However, DHSC had to purchase 20,000 Pulse Oximeters at pace to allocate to the Pilot's patients and these were in short supply and high demand in April 2020, as a number of countries were rolling out a similar pilot scheme. DHSC agreed one-off supply contract for these Pulse Oximeters via Huma's supply chain to ensure stock was available immediately, and configured to meet the Pilot's specification.. Additional information: A copy of the redacted contract is provided at the following linkhttps://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kHb2/6dYIxgutqoH6wT7FRGhuKv.vO33BHUY6PZLTFcQmoqAContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
6 Mar 2021, 10:17 GMT - Award active
Not published · Not published - Contract active
Signed 17 Apr 2020, 00:00 BST · £282,218
Commercial outcome and competition
Awards Huma Therapeutics Limited Not published · Not published · active |
Contracts Contract £282,218 · signed 17 Apr 2020, 00:00 BST · active |
Bid statistics bids: 1 (lot 1) foreignBidsFromEU: 1 (lot 1) smeBids: 0 (lot 1) |
Buyer and organisations in this procedure
Department of Health and Social Care
Contracting authority GB-FTS-43Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleThe Government must protect the health and well-being of UK citizens. The COVID-19 outbreak is a Public Health Emergency of International Concern (PHEIC) as declared by the World Health Organisation on 30 Jan 2020. The WHO Director General characterised COVID-19 as a pandemic on 11 Mar 2020.COVID-19 is serious and its consequences pose a risk to life. Cabinet Office published PPN 01/20: Responding to COVID-19 on procuring with extreme urgency in March 2020 which states that contracting authorities may enter into contracts withoutcompeting or advertising the requirement where certain tests are met.1) There are genuine reasons for extreme urgency as there is a significant public health risk requiring immediate action as a result of COVID-19 2) The COVID-19 situation is novel and the Contracting Authority could not have reasonably foreseen these events3) It is not possible to comply with the timescales of another procedure due to the urgent requirement to obtain the [supplies] being contracted for. Additionally, there are many buyers competing for the same supplies. It is imperative that security of supply is maintained. Demand for equipment is high and there is little or no incentive for suppliers to participate in competitive procurement procedures. 4) The situation is not attributable to the contracting authority]This procurement was awarded in April 2020 for access to the "Medopad software as a service and Application" for a pilot in two London NHS Trusts. The supplier was selected as they hold the IPR or provision of their remote system, mobile application. This was provided pro bono for the period 20/04/20 to 31/12/20 inclusive. However, DHSC had to purchase 20,000 Pulse Oximeters at pace to allocate to the Pilot's patients, and these were in short supply and high demand in April 2020, as a number of countries were rolling out a similar pilot scheme. DHSC agreed one-off supply contract for these Pulse Oximeters via Huma's supply chain to ensure stock was available immediately, and configured to meet the Pilot's specification. |